|
PPTC7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.17349999004557E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.42369999520409E-08 |
| Normal-vs-Stage2 |
4.206500E-04 |
| Normal-vs-Stage3 |
1.07530000015288E-07 |
| Normal-vs-Stage4 |
4.97419999967441E-07 |
| Stage1-vs-Stage2 |
5.097800E-01 |
| Stage1-vs-Stage3 |
3.425000E-01 |
| Stage1-vs-Stage4 |
3.644200E-01 |
| Stage2-vs-Stage3 |
2.326400E-01 |
| Stage2-vs-Stage4 |
2.114600E-01 |
| Stage3-vs-Stage4 |
8.817800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.86899995059076E-09 |
| Normal-vs-AfricanAmerican |
1.701270E-03 |
| Normal-vs-Asian |
1.83337999999367E-05 |
| Caucasian-vs-AfricanAmerican |
6.041600E-01 |
| Caucasian-vs-Asian |
7.482200E-01 |
| AfricanAmerican-vs-Asian |
5.160000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24729999662065E-08 |
| Normal-vs-Female |
3.25950000323871E-08 |
| Male-vs-Female |
1.872820E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59766999999755E-05 |
| Normal-vs-Age(41-60Yrs) |
1.17520004838667E-09 |
| Normal-vs-Age(61-80Yrs) |
3.16870000016678E-07 |
| Normal-vs-Age(81-100Yrs) |
8.617800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.590100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.084800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.647200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.661600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.673600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.018200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.167600E-02 |
| Classical-VS-Follicular |
4.115400E-01 |
| Classical-VS-Other |
1.360180E-01 |
| Classical-VS-Normal |
2.13259999992665E-07 |
| Tall-VS-Follicular |
3.863400E-01 |
| Tall-VS-Other |
2.917800E-01 |
| Tall-VS-Normal |
1.9090000002997E-07 |
| Follicular-VS-Other |
2.774600E-01 |
| Follicular-VS-Normal |
3.02139999996953E-06 |
| Other-VS-Normal |
8.027700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.37139966049915E-10 |
| Normal-vs-N1 |
3.5014999999472E-07 |
| N0-vs-N1 |
8.473600E-01 |
|
|
